Adamantane-Resistant Influenza Infection During the 2004–05 Season

Adamantane-resistant influenza A is an emerging problem, but infections caused by resistant and susceptible viruses have not been compared. We identified adamantane resistance in 47% of 152 influenza A virus (H3N2) isolates collected during 2005. Resistant and susceptible viruses caused similar symptoms and illness duration. The prevalence of resistance was highest in children

The role of bioenergy in a climate-changing world

Bioenergy has been under intense scrutiny over the last ten years with significant research efforts in many countries taking place to define and measure sustainable practices. We describe here the main challenges and policy issues and provide policy recommendations for scaling up sustainable bioenergy approaches globally. The 2016 Intended Nationally Determined Contributions (INDCs defined under the UN Framework Convention on Climate Change) (UNFCCC) Conference of the Parties (COP21) will not reach global Greenhouse Gas (GHG) emission targets of 2 °C. Sustainable biomass production can make a significant contribution. Substantive evidence exists that many bioenergy cropping systems can bring multiple benefits and off-set environmental problems associated with fossil fuels usage as well as intensive food production and urbanization. We provide evidence that there are many approaches to land use for bioenergy expansion that do not lead to competition for food or other needs. We should focus on how to manage these approaches on a synergistic basis and how to reduce tradeoffs at landscape scales. Priorities include successful synergies between bioenergy and food security (integrated resource management designed to improve both food security and access to bioenergy), investments in technology, rural extension, and innovations that build capacity and infrastructure, promotion of stable prices to incentivize local production and use of double cropping and flex crops (plants grown for both food and non-food markets) that provide food and energy as well as other services. The sustainable production of biomass requires appropriate policies to secure long-term support to improve crop productivity and also to ensure environmental as well as economic and social benefits of bioenergy cropping systems. Continuous support for cropping, infrastructure, agricultural management and related policies is needed to foster positive synergies between food crops and bioenergy production. In comparison to fossil fuels, biofuels have many positive environmental benefits. Potential negative effects caused by land-use change and agriculture intensification can be mitigated by agroecological zoning, best management practices, the use of eco-hydrology and biodiversity-friendly concepts at field, watershed and landscape scales. Global climate and environmental changes related to the use of fossil fuels and inequitable development make it unethical not to pursue more equitable energy development that includes bioenergy. To achieve sustainable development, competitiveness and costs of bioenergy production need to be addressed in a manner that considers not only economic gains but also development of local knowledge and social and environmental benefits.BT/Biotechnology and Societ

Fetal gene therapy for neurodegenerative disease of infants

For inherited genetic diseases, fetal gene therapy offers the potential of prophylaxis against early, irreversible and lethal pathological change. To explore this, we studied neuronopathic Gaucher disease (nGD), caused by mutations in GBA. In adult patients, the milder form presents with hepatomegaly, splenomegaly and occasional lung and bone disease; this is managed, symptomatically, by enzyme replacement therapy. The acute childhood lethal form of nGD is untreatable since enzyme cannot cross the blood–brain barrier. Patients with nGD exhibit signs consistent with hindbrain neurodegeneration, including neck hyperextension, strabismus and, often, fatal apnea1. We selected a mouse model of nGD carrying a loxP-flanked neomycin disruption of Gba plus Cre recombinase regulated by the keratinocyte-specific K14 promoter. Exclusive skin expression of Gba prevents fatal neonatal dehydration. Instead, mice develop fatal neurodegeneration within 15 days2. Using this model, fetal intracranial injection of adeno-associated virus (AAV) vector reconstituted neuronal glucocerebrosidase expression. Mice lived for up to at least 18 weeks, were fertile and fully mobile. Neurodegeneration was abolished and neuroinflammation ameliorated. Neonatal intervention also rescued mice but less effectively. As the next step to clinical translation, we also demonstrated the feasibility of ultrasound-guided global AAV gene transfer to fetal macaque brains